Trial
NCT05563948
Repeated Administration of Cannabis Varying in THC and CBD
Phase IISUSPENDEDOTHER/UNKNOWNConfidence: LOW
Sponsor
New York State Psychiatric Institute
Collaborators
—
Condition
Cannabis
Intervention
Cannabis
Why stopped
In response to quality assurance and compliance concerns, OHRP issued an FWA restriction on NYSPI research that included a pause of human research as of June 23, 2023.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-13